A Stayton patient, hospitalized at OHSU with a rare form of cancer, gets married with health care staff as witnesses.

Profile on the career of Jorge Cortes, M.D., mentions his early collaboration with Brian Druker, M.D., in the area of targeted therapies.

Story on long COVID, in which Aluko Hope, M.D., notes doctors are still learning about the chronic condition.

In a story by The Oregonian about the rise of tele-therapy during the pandemic, Sydney Ey, Ph.D., says, “I think telehealth could end up being incredibly helpful and address a huge problem that exists worldwide – access to more mental health treatment.”

Nicholas Gideonse, M.D., and his federal lawsuit challenging the residency requirement for Oregon’s aid-in-dying law. He says, “This is an action in support of a needed and very important service. I’m optimistic.”

The number of people in Oregon hospitalized with COVID-19 will stay above 400 statewide through Thanksgiving, Christmas and New Year’s, according to the forecast from Oregon Health & Science University, Portland.

Another surge is not expected, but neither is a steep decline, according to OHSU's Peter Graven, M.D.

Although depression, anxiety and psychosis are interconnected in people with Parkinson’s disease, Joseph Quinn, M.D., says they should be diagnosed and treated separately, adding therapy can help ease depression and anxiety but can’t help with psychosis.

OHSU Casey Eye Institute is named one of the top U.S. ophthalmology programs.

Lewis & Clark College neurobiologist Tamily Weissman, Ph.D., receives a $30,000 grant from the Collins Medical Trust, which will enable continue work with the lab of Vivek Unni, M.D., Ph.D., involving mechanisms that cause neurodegenerative diseases such as Parkinson’s, Alzheimer’s and Huntington’s.